港股午評：科網股、醫藥類股大跌，恆生科技指數重挫3.57%
港股上午盤再度大跌，科網股再度重挫拖累市場情緒降至冰點，致恆生科技指數大跌3.57%報5828點，恆指大跌2.28%報24739點，國指大跌2.34%報8707點。
盤面上，大型科網股美團暴跌逾7%，網易大跌6%，京東大跌3%，小米、阿里巴巴跌超2%，騰訊、百度等均下跌；醫藥類股全線大跌，平安好醫生暴跌逾15%，阿里健康、京東健康均大跌超11%，復星醫藥大跌近9%，四環醫藥大跌超7%；煙草概念股、醫美股、教育股、汽車股、體育用品股、濠賭股、石油股、三胎概念、啤酒、白酒、餐飲等消費股皆大跌。 另一方面，惟鈦白粉、半導體少數個股上漲。南下資金半日淨流出9.64億港元，大市半日成交額為1117億港元。
科技股股災！阿里/嗶哩嗶哩/快手創上市新低、騰訊創15個月新低。
隔夜美股中概股集體下挫拖累，今早港股市場科技股繼續下跌，阿里巴巴、嗶哩嗶哩、快手創上市新低；騰訊創15個月新低，較最高價回撤46%；美團跌破200港元關口，較最高價回撤58%。 經濟日報今早發“維穩”文章稱，今年以來，有關部門密集出台一系列新監管措施，尤其是在互聯網、校外培訓整頓方面下了“猛藥”。強監管下，“陣痛”不可避免，但更多是機遇。我國支持健全資本市場、弘揚企業家精神和堅持對外開放的信心不會動搖。加強對平台經濟的監管，恰恰表明中國大力發展數字經濟的決心。應該看到，我國數字經濟快速增長的趨勢不會改變，我國數字經濟引領全球發展的勢頭也同樣不會改變。
互聯網醫療股重挫，央媒提出有效保障互聯網處方用藥安全。
人民時評刊文稱，目前，我國各類互聯網醫院已達1600多家，通過互聯網醫院複診購藥日益普及。在互聯網上嚴守處方藥到患者的“最後一公里”，確保用藥安全，事關人民羣眾身體健康，也是推動“互聯網+醫療健康”新業態健康有序發展的重要方面。加快完善互聯網診療、處方用藥辦法，更好保障就醫購藥服務需求，讓人們在線上線下都能安心就醫購藥，我們就能以行動不斷提高人民健康水平，推進健康中國建設。
石油股普跌，國際原油期貨連續六個交易日收跌。
美國頁巖油產量再次上升，然而燃料需求受到新冠疫情復甦的打擊。國際原油期貨連續六個交易日收跌，創去年2月28日以來最長連跌日。美國WTI原油在美股盤中一度跌破63美元，日內跌超4%，布倫特原油盤中曾跌破66美元，日內最大跌幅接近3.9%。最終，WTI 9月原油期貨收跌2.70%，報63.69美元/桶，連續兩日創5月21日以來主力合約收盤新低。
嗶哩嗶哩(9626.HK)創上市新低。
隔夜美股嗶哩嗶哩收跌6.03%報64.33美元，折算成港股市場價格為501.09港元。 公司昨晚公佈業績顯示，2021年第二季度總淨營收為人民幣44.953億元(約合6.962億美元)，同比增72%；調整後淨虧損為人民幣8.578億元(約合1.329億美元)，上年同期為人民幣4.757億元。
恆大汽車(0708.HK)高開低走，午間收跌4%。
近日有外媒稱，中國恆大集團正與小米集團洽談出售恆大汽車65%股份，恆大今早發佈聲明稱：恆大汽車在戰略股東引進過程中，曾與小米集團有過初步交流，並未深入洽談推進。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
